Intelligence Platform

Patents

Browse 369 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7956054

Dual-acting pyrazole antihypertensive agents

Theravance, Inc. · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7947710

Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7943772

Crystalline forms of an 8-azabicyclo(3.2.1)octane compound

Theravance, Inc. · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7939689

Short-acting sedative hypnotic agents for anesthesia and sedation

Theravance, Inc. · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7910608

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7902221

Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7902148

Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial a

Theravance, Inc. · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7902220

8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

Theravance, Inc. · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7897775

Crystalline form of a benzimidazole-carboxamide medicinal compound

Theravance, Inc. · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7893256

Azabicycloalkane compounds

Theravance, Inc. · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7888386

3-(phenoxyphenylmethyl)pyrrolidine compounds

Theravance, Inc. · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7879879

Biphenyl derivatives

Theravance, Inc. · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7880010

Crystalline forms of a dimethylphenyl compound

Theravance, Inc. · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7879896

Dual-acting imidazole antihypertensive agents

Theravance, Inc. · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7875629

Quinolinone compounds as 5-HT4 receptor agonists

Theravance, Inc. · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7871997

Cephalosporin compounds

Theravance, Inc. · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7868175

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7863309

Dual-acting antihypertensive agents

Theravance, Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7858795

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7858583

Process for purifying glycopeptide phosphonate derivatives

Theravance, Inc. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7858792

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7858797

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7855221

Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

Theravance, Inc. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7851631

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted